Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06033664 · ClinicalTrials.gov registry record · NA

Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes

A NA study of Hypertension and Type 2 Diabetes Mellitus, sponsored by Alison Gustafson.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06033664 is a NA study of Hypertension and Type 2 Diabetes Mellitus that has completed, run by Alison Gustafson. The registered enrollment target is 50 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06033664, a NA study of Hypertension and Type 2 Diabetes Mellitus, has completed, sponsored by Alison Gustafson.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of a grocery prescription program in adults diagnosed with either Type 2 Diabetes Mellitus or Hypertension. Participants will enroll in Instacart Fresh Funds program. Once enrolled each week participants will select foods that are eligible in the Fresh Funds Program to be delivered to their home for 12 weeks. Participants will also participate in a survey at the beginning of the study and at the end of the study.

Interventions

  • BEHAVIORAL Fresh Funds

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-11-06
Est. Completion 2024-05-08
Phase NA

Sponsor

Alison Gustafson

5 total trials

What the Registry Record Tells You About NCT06033664

The ClinicalTrials.gov registry entry for NCT06033664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Alison Gustafson, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Fresh Funds is the first listed.

NCT06033664 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT06033664 about?

NCT06033664 is a clinical study titled "Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes". The purpose of this study is to evaluate the effectiveness of a grocery prescription program in adults diagnosed with either Type 2 Diabetes Mellitus or Hypertension. Participants will enroll in Instacart Fresh Funds program. Once enrolled each week participants will select foods that are eligible i...

What is the current status of trial NCT06033664?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-11-06. Estimated completion is 2024-05-08.

What conditions does trial NCT06033664 study?

This clinical trial studies the following conditions: Hypertension, Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT06033664?

The interventions under investigation include: Fresh Funds (BEHAVIORAL).

Who is sponsoring clinical trial NCT06033664?

This trial is sponsored by Alison Gustafson, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06033664 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.